Purpurea glycoside A is a cardiac glycoside isolated from the plant Digitalis purpurea, acting as a crucial natural precursor to clinically active pharmaceutical agents such as digoxin, which are used… Read more
Purpurea glycoside A is a cardiac glycoside isolated from the plant Digitalis purpurea, acting as a crucial natural precursor to clinically active pharmaceutical agents such as digoxin, which are used to treat heart failure and specific arrhythmias. By inhibiting the sodium-potassium ATPase pump, this compound increases intracellular calcium levels to enhance myocardial contractility. The category features a range of high-quality reference standards of Purpurea glycoside A, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing rigorous analytical testing, method validation, and impurity profiling. By providing consistent analytical benchmarks, these compounds ensure the accuracy of quality control protocols during the research and development of cardiac medication.